https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Wed, 25 Aug 2021 11:23:14 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png https://mirror.vjregenmed.com 32 32 https://mirror.vjregenmed.com/video/_abzty1a2k0-future-of-anti-bcma-car-t-cell-therapy-in-myeloma/ Thu, 08 Oct 2020 14:08:12 +0000 http://13.40.107.223/video/_abzty1a2k0-future-of-anti-bcma-car-t-cell-therapy-in-myeloma/ Noopur Raje, MD, Massachussetts General Hospital, Boston, MA, discusses areas of improvement in anti-BCMA CAR T-cell therapy in multiple myeloma, including evaluating the durability of response to CAR T-cell therapy, as well as the use of off-the-shelf allogeneic CAR-T. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

]]> https://mirror.vjregenmed.com/video/6tzufy0xxpe-current-car-t-climate-in-multiple-myeloma/ Wed, 30 Sep 2020 13:13:12 +0000 http://13.40.107.223/video/6tzufy0xxpe-current-car-t-climate-in-multiple-myeloma/ Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, gives an overview of the current CAR-T climate in the field of multiple myeloma. Dr Raje highlights the results of the KarMMa study (NCT03361748), CARTITUDE-1 (NCT03548207), and EVOLVE (NCT03430011), all evaluating different BCMA-targeting CAR T-cell therapies that show activity in multiple myeloma. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

]]>